Rosacea study tops dermatology reads for week

Study results showing that rosacea is associated with autoimmune comorbidities was among the most-read article of the past week on Healio.com/Dermatology.

Other widely read articles included findings that younger women who tanned indoors experienced up to a 6-fold likelihood of developing melanoma, and that sirolimus use in solid-organ transplant recipients lowered risk of subsequent skin cancer:

Rosacea associated with RA, diabetes, celiac disease, multiple sclerosis

Rosacea had a significant association with type 1 diabetes mellitus, celiac disease, multiple sclerosis and rheumatoid arthritis, according to recently published study results.

Researchers in Denmark conducted a population-based, case-control study of 6,759 patients with rosacea (63.2% women; mean age, 40.2 years) and 33,795 controls matched on age, sex and calendar time. Conditional logistic regression was used to calculate ORs. Read more

Indoor tanning likely factor in melanoma diagnosis among younger women

Younger women who tanned indoors experienced up to a 6-fold likelihood of developing melanoma, which was particularly true for women in their 20s, according to study results recently published in JAMA Dermatology.

Researchers in Minnesota conducted a population-based case control study of 681 patients (68.3% women) diagnosed with melanoma between 2004 and 2007, and 654 controls patients (68.2% women), aged 25 to 49 years. Read more

Troy Aikman joins advanced melanoma awareness initiative

Troy Aikman, Pro Football Hall of Famer and a former melanoma patient, has joined Novartis’ new initiative to educate patients and caregivers about advanced melanoma, according to a press release.

The initiative, called “Melanoma Just Got Personal,” will provide educational resources to help people learn more about the disease and support for those with advanced melanoma, according to the release. Read more

FDA warns skin whitening cream includes risk of mercury poisoning

The FDA has issued a warning to consumers not purchase a skin whitening cream called “Crema Piel De Seda” because of the risk of mercury poisoning.

An FDA laboratory analysis has identified mercury in the product, according to a MedWatch Safety Alert. Read more

Researchers studied 15 patients (average age, 25 years; nine males) who were seeking treatment of different types of postacne atrophic scars. Read more

Incidence of late reactions to Juvéderm Volbella higher than expected

Patients in Israel who received injections of Juvéderm Volbella in the tear trough area or lips had a higher than expected incidence of late cutaneous reactions, according to study results.

Researchers examined the medical records of 400 patients (360 women; average age, 49.6 years) who were treated with Juvéderm Volbella (hyaluronic acid) filler at four medical centers in Israel.  Read more

Sirolimus use in solid-organ transplant recipients lowered risk of subsequent skin cancer

Solid-organ transplant recipients who took sirolimus after developing posttransplant cancer had a lower risk for subsequent skin cancer, according to recent study results published in JAMA Dermatology.

Researchers conducted a retrospective cohort study from 2000 through 2008 at two academic tertiary care centers.  Read more

Study results showing that rosacea is associated with autoimmune comorbidities was among the most-read article of the past week on Healio.com/Dermatology.

Other widely read articles included findings that younger women who tanned indoors experienced up to a 6-fold likelihood of developing melanoma, and that sirolimus use in solid-organ transplant recipients lowered risk of subsequent skin cancer:

Rosacea associated with RA, diabetes, celiac disease, multiple sclerosis

Rosacea had a significant association with type 1 diabetes mellitus, celiac disease, multiple sclerosis and rheumatoid arthritis, according to recently published study results.

Researchers in Denmark conducted a population-based, case-control study of 6,759 patients with rosacea (63.2% women; mean age, 40.2 years) and 33,795 controls matched on age, sex and calendar time. Conditional logistic regression was used to calculate ORs. Read more

Indoor tanning likely factor in melanoma diagnosis among younger women

Younger women who tanned indoors experienced up to a 6-fold likelihood of developing melanoma, which was particularly true for women in their 20s, according to study results recently published in JAMA Dermatology.

Researchers in Minnesota conducted a population-based case control study of 681 patients (68.3% women) diagnosed with melanoma between 2004 and 2007, and 654 controls patients (68.2% women), aged 25 to 49 years. Read more

Troy Aikman joins advanced melanoma awareness initiative

Troy Aikman, Pro Football Hall of Famer and a former melanoma patient, has joined Novartis’ new initiative to educate patients and caregivers about advanced melanoma, according to a press release.

The initiative, called “Melanoma Just Got Personal,” will provide educational resources to help people learn more about the disease and support for those with advanced melanoma, according to the release. Read more

FDA warns skin whitening cream includes risk of mercury poisoning

The FDA has issued a warning to consumers not purchase a skin whitening cream called “Crema Piel De Seda” because of the risk of mercury poisoning.

An FDA laboratory analysis has identified mercury in the product, according to a MedWatch Safety Alert. Read more

Researchers studied 15 patients (average age, 25 years; nine males) who were seeking treatment of different types of postacne atrophic scars. Read more

Incidence of late reactions to Juvéderm Volbella higher than expected

Patients in Israel who received injections of Juvéderm Volbella in the tear trough area or lips had a higher than expected incidence of late cutaneous reactions, according to study results.

Researchers examined the medical records of 400 patients (360 women; average age, 49.6 years) who were treated with Juvéderm Volbella (hyaluronic acid) filler at four medical centers in Israel.  Read more

Sirolimus use in solid-organ transplant recipients lowered risk of subsequent skin cancer

Solid-organ transplant recipients who took sirolimus after developing posttransplant cancer had a lower risk for subsequent skin cancer, according to recent study results published in JAMA Dermatology.

Researchers conducted a retrospective cohort study from 2000 through 2008 at two academic tertiary care centers.  Read more